Se encuentra usted aquí

Usted está aquí: Inicio » Publicaciones

Publicaciones

 

A continuación se encuentran artículos publicados en revistas indexadas en los cuales han participado miembros del Departamento de Medicina Respiratoria Infantil en calidad de autores y coautores. Solamente se han incluido las publicaciones desde 2014 a 2021.

 

PUBLICACIONES DE ARTICULOS EN REVISTAS INDEXADAS 

 

  1. Hospital admission for symptoms exacerbation in 2,075 infants suffering from recurrent asthma-like symptoms: (EISL-3 South America).Mallol J, Solé D, Aranda C, Toledo EC, Aguirre V, Urrutia-Pereira M, et al.; EISL Phase 3 Study Group South America. Allergol Immunopathol (Madr). 2021 Jul 1;49(4):47-54. doi: 10.15586/aei.v49i4.100.
  2. Prevalence and Determinants of Tobacco Smoking Among Low-Income Urban Adolescents.Mallol J, Urrutia-Pereira M, Mallol-Simmonds MJ, Calderón-Rodríguez L, Osses-Vergara F, Matamala-Bezmalinovic A. Pediatr Allergy Immunol Pulmonol. 2021 Jun;34(2):60-67. doi: 10.1089/ped.2021.0018.
  3.  Response to the letter of Dr. Helmi Ben Saad.
  4. Mallol J.Allergol Immunopathol (Madr). 2021 Mar 1;49(2):228-229. doi: 10.15586/aei.v49i2.205. eCollection 2021.PMID: 33641313 No abstract available.
  5. Associated factors with recurrent wheezing in infants: is there difference between the sexes?Ferreira WFDS, Carvalho DS, Wandalsen GF, Solé D, Sarinho ESC, Medeiros D, et al. J Pediatr (Rio J). 2021 Feb 7:S0021-7557(21)00024-3. doi: 10.1016/j.jped.2021.01.001.
  6.  Author response.Larenas-Linnemann D, Romero-Tapia S, Virgen C, Mallol J, Baeza Bacab MA, García-Marcos L. Ann Allergy Asthma Immunol. 2020 Jul;125(1):116. doi: 10.1016/j.anai.2020.05.010..
  7. Value of bronchial reversibility to salbutamol, exhaled nitric oxide and responsiveness to methacholine to corroborate the diagnosis of asthma in children. 
  8. Mallol J, Riquelme C, Aguirre V, Martínez M, Gallardo A, Sánchez C, Córdova P. Allergol Immunopathol (Madr). 2020 May-Jun;48(3):214-222. doi: 10.1016/j.aller.2019.11.001.
  9.  Risk factors for wheezing in primary health care settings in the tropics.Larenas-Linnemann D, Romero-Tapia SJ, Virgen C, Mallol J, Baeza Bacab MA, et al.. Ann Allergy Asthma Immunol. 2020 Feb;124(2):179-184.e1. doi: 10.1016/j.anai.2019.11.008.
  10.  Changes in the prevalence of asthma and related risk factors in adolescents: Three surveys between 1994 and 2015.Mallol J, Aguirre V, Mallol-Simmonds M, Matamala-Bezmalinovic A, Calderón-Rodriguez L, Osses-Vergara F.Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):313-321. doi: 0.1016/j.aller.2018.10.001.
  11.  Combined impact of healthy lifestyle factors on risk of asthma, rhinoconjunctivitis and eczema in school children: ISAAC phase III.Morales E, Strachan D, Asher I, Ellwood P, Pearce N, et al., ISAAC phase III study group; ISAAC Phase Three Study Group.Thorax. 2019 Jun;74(6):531-538. doi: 10.1136/thoraxjnl-2018-212668.
  12.  Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?Rutter CE, Silverwood RJ, Williams HC, Ellwood P, Asher I, Garcia-Marcos L, et al; ISAAC Phase Three Study Group. J Invest Dermatol. 2019 May;139(5):1023-1036. doi: 10.1016/j.jid.2018.08.035.
  13. Can environment or allergy explain international variation in prevalence of wheeze in childhood?Weinmayr G, Jaensch A, Ruelius AK, Forastiere F, Strachan DP; ISAAC Phase Two Study Group.Eur J Epidemiol. 2019 May;34(5):509-520. doi: 10.1007/s10654-018-0463-z.
  14.  Are environmental risk factors for current wheeze in the International Study of Asthma and Allergies in Childhood (ISAAC) phase three due to reverse causation?Silverwood RJ, Rutter CE, Mitchell EA, Asher MI, Garcia-Marcos L, et al; ISAAC Phase Three Study Group.Clin Exp Allergy. 2019 Apr;49(4):430-441. doi: 10.1111/cea.13325. 
  15.  Prevalence of recurrent wheezing during the first year of life in Setúbal district, Portugal.D'Elia C, Mallol J, Solé D.Allergol Immunopathol (Madr). 2019 Mar-Apr;47(2):122-127. doi: 10.1016/j.aller.2018.04.006.
  16. Changes in the prevalence and severity of recurrent wheezing in infants: The results of two surveys administered 7 years apart.Mallol J, Solé D, Aguirre V, Chong H, Rosario N, García-Marcos L; EISL Study Group.J Asthma. 2018 Nov;55(11):1214-1222. doi: 10.1080/02770903.2017.1403625.
  17. Temporal comparison of wheezing prevalence in the first year of life in São Paulo: International study of wheezing in infants.Aranda CS, Wandalsen GF, Bianca ACCD, Dantas EO, Mallol J, Solé D.Rev Paul Pediatr. 2018 Oct-Dec;36(4):445-450. doi: 10.1590/1984-0462/;2018;36;4;00016.
  18. Recurrent wheezing: prevalence and associated factors in infants from Buenos Aires City, Argentina.Szulman GA, Freilij H, Behrends I, Gentile Á, Mallol J. Bol Med Hosp Infant Mex. 2017 Nov-Dec;74(6):419-426. doi: 10.1016/j.bmhimx.2017.08.001.
  19. Body mass index and vigorous physical activity in children and adolescents: an international cross-sectional study.Braithwaite IE, Stewart AW, Hancox RJ, Murphy R, Wall CR, Beasley R, Mitchell EA; ISAAC Phase Three Study Group.Acta Paediatr. 2017 Aug;106(8):1323-1330. doi: 10.1111/apa.13903
  20.  Wheezing and the first thousand days of life.Aranda CS, Wandalsen GF, Dela Bianca AC, Moraes L, Lamenha Medeiros M, Mallol J, Solé D.Pediatr Allergy Immunol. 2017 Jun;28(4):397-400. doi: 10.1111/pai.12710
  21. Prevalence and factors associated with smoking among adolescents.Urrutia-Pereira M, Oliano VJ, Aranda CS, Mallol J, Solé D.J Pediatr (Rio J). 2017 May-Jun;93(3):230-237. doi: 10.1016/j.jped.2016.07.003.
  22. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.Ellwood P, Asher MI, Billo NE, Bissell K, Chiang CY, Ellwood EM, et al. Eur Respir J. 2017 Jan 11;49(1):1601605. doi: 10.1183/13993003.01605-2016.
  23. Factors associated to recurrent wheezing in infants under one year of age in the province of Salamanca, Spain: Is intervention possible? A predictive model.Pellegrini-Belinchón J, Lorente-Toledano F, Galindo-Villardón P, González-Carvajal I, et al.. Allergol Immunopathol (Madr). 2016 Sep-Oct;44(5):393-9.
  24. Factors associated with the time to the first wheezing episode in infants: a cross-sectional study from the International Study of Wheezing in Infants (EISL).Pacheco-Gonzalez RM, Mallol J, Solé D, Brand PL, Perez-Fernandez V, et al; EISL Study Group. NPJ Prim Care Respir Med. 2016 Jan 21;26:15077
  25. Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants.Mallol J, Solé D, Garcia-Marcos L, Rosario N, Aguirre V, Chong H, et al; EISL Latin American Group. Allergy Asthma Immunol Res. 2016 Jan;8(1):22-31.
  26. Risk factors for recurrent wheezing--International Study of Wheezing in Infants (EISL) phase 3.Aranda CS, Wandalsen G, Fonzar L, Bianca AC, Mallol J, Solé D. Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):3-8. 
  27. Effect of once-daily generic ciclesonide on exhaled nitric oxide in atopic children with persistent asthma.Mallol J, Aguirre V, Gallardo A, Cortez E, Sánchez C, Riquelme C, Córdova P, Martínez M, Galindo A. Allergol Immunopathol (Madr). 2016 Mar-Apr;44(2):106-12.  
  28. Prevalence of asthma and related symptoms in adolescents: findings from 3 surveys.Solé D, Rosário Filho N, Sarinho EC, Silva AR, Britto M, Riedi C, Cardozo C, Camelo-Nunes I C, De Andrade D, Mallol J. J Investig Allergol Clin Immunol. 2015;25(1):73-4.  
  29. Pneumonia and wheezing in the first year: An international perspective.Garcia-Marcos L, Mallol J, Solé D, Brand PL, Martinez-Torres A, Sanchez-Solis M; EISL Study Group. Pediatr Pulmonol. 2015 Dec;50(12):1277-85.  
  30. Gender differences in the relationship between body mass index (BMI) changes and the prevalence and severity of wheezing and asthma in the first year of life.Wandalsen GF, Borges LV, Barroso N, Rota R, Suano F, Mallol J, Solé D; Brazilian EISL Group. Allergol Immunopathol (Madr). 2015 Nov-Dec;43(6):562-7.
  31. A multinational study to compare prevalence of atopic dermatitis in the first year of life.Draaisma E, Garcia-Marcos L, Mallol J, Solé D, Pérez-Fernández V, Brand PL; EISL Study Group. Pediatr Allergy Immunol. 2015 Jun;26(4):359-66.
  32. Fast-food consumption and body mass index in children and adolescents: an international cross-sectional study.Braithwaite I, Stewart AW, Hancox RJ, Beasley R, Murphy R, Mitchell EA; ISAAC Phase Three Study Group; ISAAC Phase Three Study Group. BMJ Open. 2014 Dec 8;4(12):e005813.
  33. [Prevalence and clinical characteristics of wheezing in children in the first year of life, living in Cuiabá, Mato Grosso, Brazil].Moraes LS, Takano OA, Mallol J, Solé D. Rev Paul Pediatr. 2014 Dec;32(4):313-9.
  34. Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two.Weinmayr G, Forastiere F, Büchele G, Jaensch A, Strachan DP, Nagel G; ISAAC Phase Two Study Group. PLoS One. 2014 Dec 4;9(12):e113996. Erratum in: PLoS One. 2015;10(4):e0126678.  
  35. Wheezing and low birthweight.Aranda CS, Wandalsen GF, Mallol J, Solé D; Brazilian EISL Group. Pediatr Allergy Immunol. 2015 Feb;26(1):82-5.
  36. Fraction of exhaled nitric oxide in healthy Chilean schoolchildren aged 8-15 years. Mallol J, Aguirre V, Córdova P, Cortez E, Gallardo A, Riquelme C. Allergol Immunopathol (Madr). 2015 Nov-Dec;43(6):528-32. 
  37. [Prevalence of atopy in 1,199 asthmatic children from southern Santiago, Chile]. Mallol J, Raby P, Cambiazo D, Peñaloza C, Palma R, De Orúe M. Rev Med Chil. 2014 May;142(5):567-73. 
  38. Association between breastfeeding and body mass index at age 6-7 years in an international survey.Hancox RJ, Stewart AW, Braithwaite I, Beasley R, Murphy R, Mitchell EA; ISAAC Phase Three Study Group. Pediatr Obes. 2015 Aug;10:283-7.
  39. Childhood intermittent and persistent rhinitis prevalence and climate and vegetation: a global ecologic analysis.Fuertes E, Butland BK, Ross Anderson H, Carlsten C, Strachan DP, Brauer M; ISAAC Phase Three Study Group. Ann Allergy Asthma Immunol. 2014 Oct;113(4):386-92.e9.
  40. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012).Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. J Pediatr (Rio J). 2015 Jan-Feb;91(1):30-5.
  41. Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood.Strachan DP, Aït-Khaled N, Foliaki S, Mallol J, Odhiambo J, Pearce N, Williams HC; ISAAC Phase Three Study Group. Clin Exp Allergy. 2015 Jan;45(1):126-36.
  42. Birthweight and the risk of atopic diseases: the ISAAC Phase III study.Mitchell EA, Clayton T, García-Marcos L, Pearce N, Foliaki S, Wong G; ISAAC Phase Three Study Group. Pediatr Allergy Immunol. 2014 May;25(3):264-70.
  43. Prevalence and risk factors associated with wheezing in the first year of life.Bessa OA, Leite ÁJ, Solé D, Mallol J. J Pediatr (Rio J). 2014 Mar-Apr;90(2):190-6.
  44. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study.Murphy R, Stewart AW, Braithwaite I, Beasley R, Hancox RJ, Mitchell EA; ISAAC Phase Three Study Group. Int J Obes (Lond). 2014 Aug;38(8):1115-9.
  45. Treatment of wheezing in Brazilian infants in the first year of life.Cavalcanti Dela Bianca AC, Wandalsen G, Prestes E, Lamenha M, Bessa O, Chong Neto H, et al. Pediatr Allergy Immunol. 2014 Mar;25(2):201-3. doi: 10.1111/pai.12144.

ACTUALIZADO: Septiembre 2021